JPS63105683A - Separation method for highly unsaturated fatty acid - Google Patents
Separation method for highly unsaturated fatty acidInfo
- Publication number
- JPS63105683A JPS63105683A JP61251397A JP25139786A JPS63105683A JP S63105683 A JPS63105683 A JP S63105683A JP 61251397 A JP61251397 A JP 61251397A JP 25139786 A JP25139786 A JP 25139786A JP S63105683 A JPS63105683 A JP S63105683A
- Authority
- JP
- Japan
- Prior art keywords
- liquid
- lipase
- fatty acid
- highly unsaturated
- unsaturated fatty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000021122 unsaturated fatty acids Nutrition 0.000 title claims abstract description 13
- 150000004670 unsaturated fatty acids Chemical class 0.000 title claims abstract description 13
- 238000000926 separation method Methods 0.000 title claims description 9
- 239000004367 Lipase Substances 0.000 claims abstract description 26
- 102000004882 Lipase Human genes 0.000 claims abstract description 26
- 108090001060 Lipase Proteins 0.000 claims abstract description 26
- 235000019421 lipase Nutrition 0.000 claims abstract description 26
- 230000005526 G1 to G0 transition Effects 0.000 claims abstract description 22
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 17
- 238000000622 liquid--liquid extraction Methods 0.000 claims abstract description 15
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 10
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 9
- 229930195729 fatty acid Natural products 0.000 claims abstract description 9
- 239000000194 fatty acid Substances 0.000 claims abstract description 9
- 235000021588 free fatty acids Nutrition 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 12
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 claims description 9
- 241000235395 Mucor Species 0.000 claims description 5
- 235000014593 oils and fats Nutrition 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 241000228212 Aspergillus Species 0.000 claims description 2
- 241000588881 Chromobacterium Species 0.000 claims description 2
- 241000589516 Pseudomonas Species 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims 1
- 235000019197 fats Nutrition 0.000 abstract description 14
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract description 9
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract description 8
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract description 6
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract description 6
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract description 2
- 244000005700 microbiome Species 0.000 abstract description 2
- 238000004810 partition chromatography Methods 0.000 abstract description 2
- 230000036425 denaturation Effects 0.000 abstract 1
- 238000004925 denaturation Methods 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 28
- 239000012071 phase Substances 0.000 description 21
- 208000015707 frontal fibrosing alopecia Diseases 0.000 description 17
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- 239000003925 fat Substances 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000007791 liquid phase Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000021323 fish oil Nutrition 0.000 description 5
- 125000005456 glyceride group Chemical group 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000001133 acceleration Effects 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- -1 methanol and ethanol Chemical class 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000005192 partition Methods 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000146387 Chromobacterium viscosum Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000010698 whale oil Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- FKCBLVCOSCZFHV-UHFFFAOYSA-N acetonitrile;ethanol Chemical compound CCO.CC#N FKCBLVCOSCZFHV-UHFFFAOYSA-N 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はエイコサペンタエン酸(以下、EPAと略す)
、ドコサヘキサエン酸(以下、DHAと略す)などの高
度不飽和脂肪酸(以下、PUFAと略す)を脂肪酸成分
として含有する天然油脂(例えば、魚油、鯨油、微生物
由来の油脂)からPUFAを選択的に分離する方法に関
するものである。[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to eicosapentaenoic acid (hereinafter abbreviated as EPA)
, selective separation of PUFA from natural fats and oils (e.g., fish oil, whale oil, microbial-derived fats and oils) containing highly unsaturated fatty acids (hereinafter abbreviated as PUFA) such as docosahexaenoic acid (hereinafter abbreviated as DHA) as fatty acid components. It's about how to do it.
EPA、 DHAには血小板の凝集抑制作用があり、脳
血栓や心筋梗塞等の@検器系疾患の予防薬としての可能
性がDyarberg博士らによる研究によって示唆さ
れている。またEPAには血液中のコレステロールを低
下させる働きがあり、その活性は現在脱コレステロール
剤として用いられているリノール酸の約4倍と言われて
いる。以上のようにPLIFAはその薬理作用が注目さ
れている。EPA and DHA have an inhibitory effect on platelet aggregation, and research by Dr. Dyarberg et al. has suggested that they may serve as preventive agents for organ-related diseases such as cerebral thrombosis and myocardial infarction. EPA also has the ability to lower cholesterol in the blood, and its activity is said to be about four times that of linoleic acid, which is currently used as a cholesterol-reducing agent. As described above, PLIFA has attracted attention for its pharmacological effects.
従来のPUFAの分離方法としては、グリセリドをメタ
ノールやエタノール等の低級アルコールのエステルに変
換した後蒸留し、さらに尿素包接処理により濃縮分離を
行う方法(例えば特開昭58−8037号)、逆相クロ
マトグラフィーを用いて濃縮分離を行う方法(例えば特
開昭58−88339号、特開昭58−109444号
)などが提案されている。Conventional PUFA separation methods include converting glycerides into esters of lower alcohols such as methanol and ethanol, distilling them, and then concentrating and separating them by urea inclusion treatment (for example, Japanese Patent Application Laid-open No. 8037-1983); A method of concentrating and separating using phase chromatography (for example, JP-A-58-88339, JP-A-58-109444) has been proposed.
一方、魚油をキャンディダ・シリンドラッセから得られ
たリパーゼにより加水分解してPUFAをグリセリド側
に濃縮し、これを遊離脂肪酸(以下、FFAと略す)か
ら分離する方法が提案されている(特開昭58−165
796号)。On the other hand, a method has been proposed in which fish oil is hydrolyzed with lipase obtained from Candida cylindrasse to concentrate PUFA into glycerides and separate this from free fatty acids (hereinafter abbreviated as FFA) (JP-A-Sho). 58-165
No. 796).
ところでPUFAはその構造上、光、熱、酸素などに対
し極めて不安定で酸化されやすく、過酸化脂質を生成し
やすい。過酸化脂質は人体に悪影響を及ぼし、下痢、嘔
吐、発熱や、最悪の場合列に至ることもある。従ってP
UFAを処理する際には常温、常圧、中性条件下での反
応が望ましい。However, due to its structure, PUFA is extremely unstable and easily oxidized to light, heat, oxygen, etc., and easily generates lipid peroxide. Lipid peroxide has a negative effect on the human body, causing diarrhea, vomiting, fever, and in the worst cases, queuing. Therefore P
When treating UFA, it is desirable to carry out the reaction at room temperature, normal pressure, and under neutral conditions.
しかるに、従来のエステル交換法による分離方法では、
PUFAを低級なアルコールのエステルに変換した後に
分離濃縮が行われているため、エステル化の過程におい
て熱、触媒、アルカリ等によってPUFAが酸化、変性
などを起こす可能性が非常に高い。However, in the conventional separation method using transesterification,
Since separation and concentration is performed after converting PUFA into a lower alcohol ester, there is a very high possibility that PUFA will be oxidized or denatured by heat, catalysts, alkalis, etc. during the esterification process.
また逆相クロマトグラフィーを用いて濃縮分離する方法
は、大量の充填剤および溶剤を1用する必要があるとと
もに処理効率が悪く、大量の処理に適しない。In addition, the method of concentration separation using reversed phase chromatography requires the use of a large amount of packing material and solvent, has poor processing efficiency, and is not suitable for large-scale processing.
さらに、従来のPUFAを含有する油脂への酵素的加水
分解の応用としてのリパーゼを用いる方法は、PUFA
を含むグリセリドがリパーゼにより加水分解されにくい
性質を利用するもので、炭素数18以下の通常の脂肪酸
部分をリパーゼにより分解して脂肪酸とし、PUFAを
未分解のままグリセリドとしてFFAから分離する方法
であるが、PUFAの分離効率が低く、高濃度に分離で
きないという問題点があった。Furthermore, the conventional method using lipase as an application of enzymatic hydrolysis to fats and oils containing PUFA
This method takes advantage of the property that glycerides containing FFA are difficult to be hydrolyzed by lipase, and is a method in which normal fatty acid parts with 18 carbon atoms or less are decomposed by lipase to become fatty acids, and PUFA is separated from FFA as glyceride without being decomposed. However, there was a problem that the separation efficiency of PUFA was low and it was not possible to separate it at a high concentration.
本発明は上記問題点を解決するためのもので、不安定な
PUFAを変性させることなく、効率よく高濃度に分離
することが可能なPUFAの分離方法を提案することを
目的としている。The present invention is intended to solve the above-mentioned problems, and aims to propose a method for separating PUFA that can efficiently separate unstable PUFA to a high concentration without denaturing it.
本発明は、高度不飽和脂肪酸を脂肪酸成分として含有す
る天然油脂をリパーゼで分解した後、遠心液々分配クロ
マトグラフィーで分画し、高度不飽和脂肪酸の遊離脂肪
酸およびモノグリセリドを含む両分を分取することを特
徴とする高度不飽和脂肪酸の分離方法である。The present invention decomposes natural fats and oils containing highly unsaturated fatty acids as fatty acid components using lipase, and then fractionates them using centrifugal liquid-liquid partition chromatography to separate both free fatty acids and monoglycerides of the highly unsaturated fatty acids. This is a method for separating highly unsaturated fatty acids.
本発明ではPUFAを低級アルコールのエステルに変換
することなく、リパーゼを用いた部分加水分解により各
種グリセリドおよびFFAの混合物として、遠心液々分
配クロマトグラフィーによって分画し、PUFAのFF
Aおよびモノグリセリドを含む両分を分取することによ
りPUFAを分離する。In the present invention, PUFAs are not converted into lower alcohol esters, but are fractionated by centrifugal liquid-liquid partition chromatography as a mixture of various glycerides and FFAs by partial hydrolysis using lipase.
PUFA is separated by fractionating both fractions containing A and monoglyceride.
本発明においてPUFAとしては、炭素数18〜24、
二重結合の数3〜6の長鎖PUFAがあり、その例とし
ては前記EPA、 DHAのほかにγ−リルン酸、アラ
キドン酸などがあげられる。本発明における原料油脂は
これらのPUFAを脂肪酸成分として含有する天然油脂
であり、魚油、鯨油、月見草種子油、松実油、微生物由
来の油脂などがあげられる。In the present invention, PUFA includes carbon atoms of 18 to 24,
There are long-chain PUFAs with 3 to 6 double bonds, examples of which include EPA and DHA, as well as γ-lylunic acid and arachidonic acid. The raw material oils and fats in the present invention are natural oils and fats containing these PUFAs as fatty acid components, and include fish oil, whale oil, evening primrose seed oil, pine seed oil, and oils and fats derived from microorganisms.
本発明で用いられるリパーゼはムコール属、クロモバク
テリウム属、シュードモナス属およびアスペルギルス属
に属するリパーゼ生産菌から得られたものが好ましい。The lipase used in the present invention is preferably obtained from lipase-producing bacteria belonging to the genus Mucor, Chromobacterium, Pseudomonas, and Aspergillus.
上記のリパーゼ生産菌としては、例えばムコール・ミニ
ハイ、クロモバクテリウム・ビスコスム、シュードモナ
ス・フルオレッセンス、アスペルギルス・ニガーなどが
あげられる。このうち一部のリパーゼ、例えばムコール
・ミニハイから得られたリパーゼにより油脂を完全にF
FAにまで分解するのは困難であるが、モノグリセリド
までの分解は可能である。Examples of the above-mentioned lipase-producing bacteria include Mucor minihai, Chromobacterium viscosum, Pseudomonas fluorescens, and Aspergillus niger. Of these, some lipases, such as those obtained from Mucor Minihai, can be used to completely remove fats and oils.
Although it is difficult to decompose it into FA, it is possible to decompose it into monoglycerides.
原料油脂をリパーゼで分解するには、その活性を発現さ
せるために水が必要であり、その量は天然油脂に対し3
0〜70重景%、好ましくは50重量%程度が適当であ
る。またリパーゼの使用量は通常天然油脂1gあたり1
0〜10000ユニツト、好ましくは100〜500ユ
ニツト程度が適当である。In order to decompose raw material fats and oils with lipase, water is required to develop its activity, and the amount of water is 3 times higher than natural fats and oils.
A suitable amount is 0 to 70% by weight, preferably about 50% by weight. The amount of lipase used is usually 1 g per 1 g of natural fat.
A suitable range is 0 to 10,000 units, preferably about 100 to 500 units.
分解の方法は上記原料油脂、リパーゼおよび水を混合し
、酵素分解に適した温和な温度、圧力で中性条件下に撹
拌し、24〜72時間反応させることができる。The decomposition can be carried out by mixing the raw material oil, lipase and water, stirring under neutral conditions at a mild temperature and pressure suitable for enzymatic decomposition, and reacting for 24 to 72 hours.
この反応において、原料油脂はリパーゼにより加水分解
され、PUFAはトリグリセリドからジグリセリド、モ
ノグリセリドを経てFFAに分解するが、PIJFAは
グリセリンのβ位に結合しているため、モノグリセリド
にもPIJFAが多量に存在している。一方、遠心液々
分配クロマトグラフィーによれば、PUFAのFFAお
よびモノグリセリドをトリグリセリド、ジグリセリド、
ならびに他の脂肪酸のFFAおよびモノグリセリドから
選択的に分離することが可能であるから、リパーゼによ
るPUFAの分解は完全にFFAにまで進行する必要は
なく、モノグリセリドまで分解されていれば、効率よ<
PUFAを分離することができる。In this reaction, raw fats and oils are hydrolyzed by lipase, and PUFA is decomposed from triglyceride to diglyceride to monoglyceride to FFA, but since PIJFA is bound to the β-position of glycerin, a large amount of PIJFA is present in monoglyceride as well. ing. On the other hand, according to centrifugal liquid-liquid partition chromatography, FFA and monoglyceride of PUFA can be converted into triglyceride, diglyceride,
Since it is possible to selectively separate PUFA from FFA and monoglycerides of other fatty acids, the decomposition of PUFA by lipase does not need to proceed completely to FFA, and if it is decomposed to monoglyceride, it is efficient.
PUFA can be separated.
こうしてリパーゼにより原料油脂を分解して生成するP
UFAおよび他の脂肪酸のトリ、ジ、モノグリセリドお
よびFFAの混合物を遠心液々分配クロマトグラフィー
により分画を行い、PUFAのモノグリセリドおよびF
FAを含む画分を分取してPUFAを分離する。In this way, lipase decomposes the raw material oil and produces P.
A mixture of UFA and other fatty acid tri-, di-, and monoglycerides and FFA was fractionated by centrifugal liquid-liquid partition chromatography, and PUFA monoglycerides and FFA were fractionated by centrifugal liquid-liquid partition chromatography.
A fraction containing FA is separated to separate PUFA.
遠心液々分配クロマトグラフィーは特開昭59−623
12号に開示されているもので、2層分離液のうち一方
を固定相として遠心力により保持しつつ、他方を移動相
として連続的に固定相内を通過させて、移動相内に注入
された試料を連続的に分画する向流分配クロマトグラフ
ィーである。Centrifugal liquid-liquid partition chromatography was published in Japanese Patent Publication No. 59-623.
No. 12, one of the two-layer separated liquid is held as a stationary phase by centrifugal force, while the other as a mobile phase is continuously passed through the stationary phase and injected into the mobile phase. This is countercurrent partition chromatography that continuously fractionates a sample.
本発明では比重および極性が異なり、2相に分離する2
種の溶媒の一方を固定相、他方を移動相とし、遠心加速
度の作用により固定相中を移動相を移動させ、試料中の
各成分を分配係数の差を利用して多段分配平衡によりク
ロマトグラフィー的に分画する。この方法では、試料中
の極性の高い成分が順次極性の高い溶媒に分配され、ま
た極性の低い成分が順次極性の低い溶媒に分配される6
図面は本発明で用いられる遠心液々分配クロマトグラフ
ィーの系統図であり、その原理は以下の通りである。In the present invention, the two phases differ in specific gravity and polarity and separate into two phases.
One of the seed solvents is used as a stationary phase and the other as a mobile phase, and the mobile phase is moved through the stationary phase by the action of centrifugal acceleration, and each component in the sample is chromatographed by multistage partition equilibrium using the difference in partition coefficient. fractionate. In this method, highly polar components in the sample are sequentially distributed into highly polar solvents, and less polar components are sequentially distributed into less polar solvents6.
The drawing is a system diagram of centrifugal liquid-liquid partition chromatography used in the present invention, and its principle is as follows.
=7−
遠心機ローターR上に多数の分配管C(500〜400
(1)が遠心加速度gの方向と平行に配列され、相互に
直列に導管Tで接続されている。導管Tの両端は遠心機
回転軸の両端に設置された回転送液ジヨイントJ7、J
7に接続されている。回転送液ジヨイントJ、、J2は
4方バルブv3.6方バルブ(試料インジェクター)v
2、定流量ポンプPおよび4方ロータリーバルブv1を
介して固定相SP、移動相HP、洗浄液wSの容器に接
続され、また4方バルブ■1、フローセルモニターMお
よび3方ロータリーバルブv4を介してフラクションコ
レクターFおよび廃液VTの容器に接続している。SL
はサンプリングループ、RCはレコーダーである。=7- A large number of distribution pipes C (500 to 400
(1) are arranged parallel to the direction of centrifugal acceleration g and are connected to each other in series by a conduit T. Both ends of the conduit T are connected to rotation transfer liquid joints J7 and J installed at both ends of the centrifuge rotation shaft.
7 is connected. Recirculation liquid joint J, J2 is a 4-way valve v3.6-way valve (sample injector)v
2. Connected to the containers of stationary phase SP, mobile phase HP, and washing liquid wS via constant flow pump P and 4-way rotary valve v1, and also via 4-way valve 1, flow cell monitor M, and 3-way rotary valve v4 Connected to fraction collector F and waste liquid VT container. SL
is a sampling loop, and RC is a recorder.
この装置を用いた遠心液々分配クロマトグラフィーは次
のような手順で行われる。比重および極性が異なり、2
相に分離する任意の溶媒を混合、静置後、重液相、軽液
相にそれぞれ分離し容器に貯える。いずれか一方の液相
(図面では重液相)を固定相spとして分配管Cに充填
した後、ローターRを回転させ、一定の遠心加速度gを
与えつつ、他方の液相(図面では軽液相)を移動相聞と
して回転軸一端の回転送液ジヨイントJ1を通して連続
的に送液する。移動相MPは遠心加速度gの作用により
固定相中SP中を微細な液滴となって分配管Cを順次通
過し、回転軸他端の回転送液ジヨイントJ2より連続的
に流出する。遠心機外部に設置されたサンプリングルー
プSLより、送液初期の一定量の移動相MP中に導入さ
れた試料成分は上記過程中に遠心液々分配クロマトグラ
フィーによりそれぞれ目的成分に分離され、その後必要
に応じてフラクションコレクターFで分画される。Centrifugal liquid-liquid partition chromatography using this device is performed according to the following procedure. Specific gravity and polarity are different, 2
After mixing any solvent that separates into phases and allowing it to stand still, the mixture is separated into a heavy liquid phase and a light liquid phase and stored in a container. After filling distribution tube C with one of the liquid phases (heavy liquid phase in the drawing) as a stationary phase sp, the rotor R is rotated and while applying a constant centrifugal acceleration g, the other liquid phase (light liquid phase in the drawing) is filled. The liquid is continuously fed through the rotation transfer liquid joint J1 at one end of the rotating shaft as a moving phase. The mobile phase MP becomes minute droplets in the stationary phase SP under the action of the centrifugal acceleration g, passes sequentially through the distribution pipe C, and continuously flows out from the rotation transfer liquid joint J2 at the other end of the rotating shaft. The sample components introduced into a certain amount of mobile phase MP at the initial stage of liquid feeding through the sampling loop SL installed outside the centrifuge are separated into target components by centrifugal liquid-liquid partition chromatography during the above process, and are then separated into the desired components. It is fractionated by fraction collector F according to the amount.
固定相SPとして極性の高い重液例えばアセトニトリル
エタノール/水(90: IOV/V)混合溶媒等を使
用し、移動相聞として極性の低い軽液例えばn−ヘキサ
ン等を使用する場合、試料中の極性が低いものまたは鎖
長の長いものから順次移動相とともに流出する。一方固
定相の流入側から極性が高いものまたは鎖長の短いもの
が順次残留することになるので、移動相の送液を反転し
て固定相を流入側から押出すと、極性が高いものまたは
鎖長の短いものが順次流出する。When using a highly polar heavy liquid such as acetonitrile ethanol/water (90: IOV/V) mixed solvent as the stationary phase SP and a low polar light liquid such as n-hexane as the mobile phase, the polarity in the sample Those with lower chain length or longer chain length are sequentially flowed out together with the mobile phase. On the other hand, those with high polarity or short chain length will remain from the inflow side of the stationary phase, so if you reverse the flow of the mobile phase and push out the stationary phase from the inflow side, those with high polarity or short chain length will remain. Those with shorter chain lengths flow out sequentially.
こうして流出する移動相中には主としてトリグリセリド
、ジグリセリド、お゛よび不飽和度の低い脂肪酸のFF
Aが含まれ、反転により最初に流出する固定相中には鎖
長の短いFFAおよびモノグリセリドが含まれ、続いて
流出する固定相中には鎖長が長く不飽和度の高い、FF
Aおよびモノグリセリドが含まれる。従って最後の固定
相画分を分取すると、PUFAを高回収率で分離するこ
とができる。The mobile phase that flows out in this way contains mainly triglycerides, diglycerides, and FF of less unsaturated fatty acids.
The stationary phase that flows out first upon inversion contains short-chain FFA and monoglyceride, and the stationary phase that flows out next contains long-chain, highly unsaturated FF.
A and monoglycerides. Therefore, by separating the final stationary phase fraction, PUFA can be separated with a high recovery rate.
以上の通り本発明によれば、天然油脂をリパーゼで分解
した後、遠心液々分配クロマトグラフィーでPUFAの
FFAおよびモノグリセリドを含む両分を分取するよう
にしたので、不安定なPUFAを変性させることなく分
離することができ、またPLIFAを完全にFFAに分
解させることなく、FFAおよびモノグリセリドの形で
分離できるため、PUFAを効率よく分離することがで
きる。As described above, according to the present invention, after decomposing natural fats and oils with lipase, both fractions of PUFA containing FFA and monoglyceride are separated by centrifugal liquid-liquid partition chromatography, so that unstable PUFA is denatured. Furthermore, since PLIFA can be separated in the form of FFA and monoglyceride without completely decomposing it into FFA, PUFA can be efficiently separated.
以下、本発明を実施例により説明する。各例中%は重量
%を示す。The present invention will be explained below using examples. In each example, % indicates weight %.
実施例1
魚油10gおよび精製水4+Jを50mρ容量のスクリ
ュー管に入れ、ムコール・ミニハイから得た酵素100
ユニツトを精製水に溶かして加え、50”Cの恒温槽中
で毎分500回転の速度で回転撹拌して、約48時間反
応を行った。分解物を第1図の構成を有する遠心液々分
配クロマトグラフcPcモデルLLN(三鬼エンヂニア
リング■製)を用いて次の条件でクロマトグラフィーに
よる分画を行った。Example 1 10g of fish oil and 4+J of purified water were placed in a screw tube with a capacity of 50 mρ, and 100 g of enzyme obtained from Mucor Minihai was added.
Unit was dissolved in purified water and added, and the reaction was carried out for about 48 hours by stirring at a speed of 500 revolutions per minute in a constant temperature bath at 50''C. Fractionation by chromatography was performed using a partition chromatograph cPc model LLN (manufactured by Miki Engineering ■) under the following conditions.
分配液としてn−ヘキサンおよびアセトニトリルを混合
後静置して分離した重液を固定相として850mfl充
填し、軽液を移動相とした。試料として上記魚油分解物
10gを50mQとなるように移動相に溶解した溶液を
注入し、その後移動相1500m12を注入して分画を
行った。このときの回転数は1000rprn、送液速
度は10n++Q/分、操作温度は20℃である。As a distribution liquid, n-hexane and acetonitrile were mixed and then allowed to stand to separate. 850 mfl of a heavy liquid was filled as a stationary phase, and a light liquid was used as a mobile phase. As a sample, a solution in which 10 g of the above fish oil decomposition product was dissolved in a mobile phase to give 50 mQ was injected, and then 1500 ml of mobile phase was injected to perform fractionation. At this time, the rotational speed was 1000 rprn, the liquid feeding rate was 10 n++Q/min, and the operating temperature was 20°C.
上記により溶出した移動相(軽液) 1500+nIl
を濃縮して画分1とし、送液方向を反転して最初に溶出
した固定相(重液) 100m+Qを濃縮して画分2と
し、その後溶出した固定相80抛Qを濃縮して画分3と
した。Mobile phase (light liquid) eluted above 1500+nIl
Concentrate to obtain fraction 1, then reverse the feeding direction and concentrate the first eluted stationary phase (heavy liquid) 100m+Q to obtain fraction 2, then concentrate the eluted stationary phase 80m+Q to obtain fraction It was set as 3.
画分1、画分2、画分3をそれぞれメタノール/クロロ
ホルム系溶剤で溶剤抽出した後、メタノールでエステル
を合成し、ガスクロマトグラフィーにより下記測定条件
で組成分析を行った。その結果を原料油脂中からのEP
A、 DHAの回収率として表1に示した。After fraction 1, fraction 2, and fraction 3 were each subjected to solvent extraction with a methanol/chloroform-based solvent, esters were synthesized with methanol, and compositional analysis was performed by gas chromatography under the following measurement conditions. The results are used for EP from raw material oils and fats.
A. The recovery rate of DHA is shown in Table 1.
なお画分1にはトリグリセリド、ジグリセリド、不飽和
度の低い脂肪酸のFFAが主に含まれ、画分2には鎖長
の短いFFAおよびモノグリセリドが主に含まれ、画分
3にはPUFAのFFAおよびモノグリセリドが主に含
まれていた。また日本油化学協会制定の基準油脂分析試
験法による過酸化物価はほとんど変化がみられなかった
。Fraction 1 mainly contains triglycerides, diglycerides, and FFAs of fatty acids with a low degree of unsaturation, fraction 2 mainly contains FFAs with short chain lengths and monoglycerides, and fraction 3 mainly contains FFAs of PUFA. and monoglycerides were mainly included. In addition, almost no change was observed in the peroxide value according to the standard oil and fat analysis test method established by the Japan Oil Chemists' Association.
ガスクロマトグラフィーの測定条件
カラム:キャビラリークロマトグラム
サーモン3000A (島津製作所製)、(φ0.24
mmX50m)
注入口、検出器温度:250℃
カラム温度: He ; 25kPa、 Air ;
30kPa、 H,; 30kPa検出器: FID
実施例2
実施例1と同様の条件でクロモバクテリウム・ビスコス
ムより得られたリパーゼを用いて反応および分画を行っ
た。その結果を表1に示した。Measurement conditions for gas chromatography Column: Cavillary chromatogram Salmon 3000A (manufactured by Shimadzu Corporation), (φ0.24
mm x 50m) Inlet, detector temperature: 250°C Column temperature: He; 25kPa, Air;
30 kPa, H,; 30 kPa detector: FID Example 2 Reaction and fractionation were performed using lipase obtained from Chromobacterium viscosum under the same conditions as in Example 1. The results are shown in Table 1.
実施例3
実施例1の条件でシュードモナス・フルオレッセンスよ
り得られたリパーゼを用いて反応および分画を行った。Example 3 A reaction and fractionation were carried out under the conditions of Example 1 using lipase obtained from Pseudomonas fluorescens.
その結果を表1に示した。The results are shown in Table 1.
表1
以上の結果より、画分3を分取することにより、PUF
Aを高収率で分離できることがわかる。Table 1 From the above results, by separating fraction 3, PUF
It can be seen that A can be separated in high yield.
図面は遠心液々分配クロマトグラフィーの系統図であり
、SPは固定相、MPは移動相、tysは洗浄液、■、
は4方ロータリーバルブ、■2は6方バルブ、V3は4
方バルブ、■4は3方ロータリーバルブ、SLはサンプ
リングループ、Pは定流量ポンプ、J、、J2は回転送
液ジヨイント、Rはローター、Cは分配管、Tは導管、
Mはフローセルモニター、RCはレコーダー、Fはフラ
クションコレクターである。The figure is a system diagram of centrifugal liquid-liquid partition chromatography, where SP is the stationary phase, MP is the mobile phase, tys is the washing solution,
is a 4-way rotary valve, ■2 is a 6-way valve, and V3 is a 4-way valve.
■4 is a three-way rotary valve, SL is a sampling loop, P is a constant flow pump, J, J2 is a recirculation liquid joint, R is a rotor, C is a distribution pipe, T is a conduit,
M is a flow cell monitor, RC is a recorder, and F is a fraction collector.
Claims (4)
然油脂をリパーゼで分解した後、遠心液々分配クロマト
グラフィーで分画し、高度不飽和脂肪酸の遊離脂肪酸お
よびモノグリセリドを含む画分を分取することを特徴と
する高度不飽和脂肪酸の分離方法。(1) Natural oils and fats containing highly unsaturated fatty acids as fatty acid components are decomposed by lipase, and then fractionated by centrifugal liquid-liquid partition chromatography to separate fractions containing free fatty acids and monoglycerides of highly unsaturated fatty acids. A method for separating highly unsaturated fatty acids.
の数3〜6のものである特許請求の範囲第1項記載の分
離方法。(2) The separation method according to claim 1, wherein the highly unsaturated fatty acid has 18 to 24 carbon atoms and 3 to 6 double bonds.
シュードモナス属、またはアスペルギルス属に属するリ
パーゼ生産菌により生産されたものである特許請求の範
囲第1項または第2項記載の分離方法。(3) The lipase is of the genus Mucor, Chromobacterium,
The isolation method according to claim 1 or 2, which is produced by a lipase-producing bacterium belonging to the genus Pseudomonas or the genus Aspergillus.
うち一方を固定相として遠心力により保持しつつ、他方
を移動相として連続的に固定相内を通過させて、移動相
内に注入された試料を連続的に分画するものである特許
請求の範囲第1項ないし第3項のいずれかに記載の分離
方法。(4) In centrifugal liquid-liquid partition chromatography, one of the two-phase separated liquids is held as a stationary phase by centrifugal force, while the other is continuously passed through the stationary phase as a mobile phase and injected into the mobile phase. The separation method according to any one of claims 1 to 3, wherein a separated sample is continuously fractionated.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61251397A JPH0787793B2 (en) | 1986-10-22 | 1986-10-22 | Method for separating highly unsaturated fatty acids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61251397A JPH0787793B2 (en) | 1986-10-22 | 1986-10-22 | Method for separating highly unsaturated fatty acids |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63105683A true JPS63105683A (en) | 1988-05-10 |
JPH0787793B2 JPH0787793B2 (en) | 1995-09-27 |
Family
ID=17222234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61251397A Expired - Fee Related JPH0787793B2 (en) | 1986-10-22 | 1986-10-22 | Method for separating highly unsaturated fatty acids |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0787793B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089403A (en) * | 1989-06-05 | 1992-02-18 | Iowa State University Research Foundation, Inc. | Process for enzymatic hydrolysis of fatty acid triglycerides with oat caryopses |
WO2008093378A1 (en) * | 2007-01-31 | 2008-08-07 | Adorkem Technology Spa | Process of selective enzymatic enrichment of a mixture containing omega-3 |
FR2915491A1 (en) * | 2007-04-27 | 2008-10-31 | Univ Nantes Etablissement Publ | METHOD OF INTENSIVE EXTRACTION OF CELLULAR COMPOUNDS FROM MICROORGANISMS, BY CONTINUOUS CULTURE AND EXTRACTION, AND CORRESPONDING DEVICE. |
JP2017141239A (en) * | 2012-02-17 | 2017-08-17 | アルクレスタ, インコーポレイテッド | Method, composition, and device for filling need for dietary fatty acid |
WO2021172151A1 (en) * | 2020-02-28 | 2021-09-02 | 株式会社カネカ | Production method for long-chain fatty acids and use thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5180305A (en) * | 1975-01-10 | 1976-07-13 | Nisshin Oil Mills Ltd | Kodofuhowashibosannoseizohoho |
JPS5962312A (en) * | 1982-09-30 | 1984-04-09 | Sanki Eng Kk | Method and device for refining physiologically active natural organic compound |
-
1986
- 1986-10-22 JP JP61251397A patent/JPH0787793B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5180305A (en) * | 1975-01-10 | 1976-07-13 | Nisshin Oil Mills Ltd | Kodofuhowashibosannoseizohoho |
JPS5962312A (en) * | 1982-09-30 | 1984-04-09 | Sanki Eng Kk | Method and device for refining physiologically active natural organic compound |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089403A (en) * | 1989-06-05 | 1992-02-18 | Iowa State University Research Foundation, Inc. | Process for enzymatic hydrolysis of fatty acid triglycerides with oat caryopses |
WO2008093378A1 (en) * | 2007-01-31 | 2008-08-07 | Adorkem Technology Spa | Process of selective enzymatic enrichment of a mixture containing omega-3 |
FR2915491A1 (en) * | 2007-04-27 | 2008-10-31 | Univ Nantes Etablissement Publ | METHOD OF INTENSIVE EXTRACTION OF CELLULAR COMPOUNDS FROM MICROORGANISMS, BY CONTINUOUS CULTURE AND EXTRACTION, AND CORRESPONDING DEVICE. |
WO2008135382A3 (en) * | 2007-04-27 | 2009-01-08 | Univ Nantes | Method for the intensive extraction of cellular compounds from micro-organisms by continuous culture and extraction, and corresponding device |
JP2010524480A (en) * | 2007-04-27 | 2010-07-22 | ユニヴェルシテ・ドゥ・ナント | Method and apparatus for intensive extraction of cellular compounds from microorganisms by continuous culture and extraction |
US8715956B2 (en) | 2007-04-27 | 2014-05-06 | Universite De Nantes | Method for the intensive extraction of cellular compounds from micro-organisms by continuous culture and extraction, and corresponding device |
JP2017141239A (en) * | 2012-02-17 | 2017-08-17 | アルクレスタ, インコーポレイテッド | Method, composition, and device for filling need for dietary fatty acid |
WO2021172151A1 (en) * | 2020-02-28 | 2021-09-02 | 株式会社カネカ | Production method for long-chain fatty acids and use thereof |
Also Published As
Publication number | Publication date |
---|---|
JPH0787793B2 (en) | 1995-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5288619A (en) | Enzymatic method for preparing transesterified oils | |
Shahidi et al. | Omega-3 fatty acid concentrates: nutritional aspects and production technologies | |
JP4236128B2 (en) | Essential oil composition | |
CA2762062C (en) | Process for extracting fatty acids from aqueous biomass in a membrane contactor module | |
WO2009154369A2 (en) | High-purity purification method for omega-3 highly unsaturated fatty acids | |
Moore et al. | Production of triglycerides enriched in long‐chain n‐3 polyunsaturated fatty acids from fish oil | |
Linder et al. | Enrichment of salmon oil with n‐3 PUFA by lipolysis, filtration and enzymatic re‐esterification | |
JPS63162796A (en) | Fractionation of fatty acid | |
IT9048587A1 (en) | MARGARINE OILS WITH LOW CONTENT OF TRANS ACIDS AND SATURATED FATTY ACIDS WITH INTERMEDIATE CHAIN, AS WELL AS ENZYMATIC TRANSESTERIFICATION PROCEDURE FOR THEIR PREPARATION. | |
JPS63105683A (en) | Separation method for highly unsaturated fatty acid | |
WO1991008676A1 (en) | Low-saturate edible oils and transesterification methods for production thereof | |
Hayes et al. | Urea-based fractionation of seed oil samples containing fatty acids and acylglycerols of polyunsaturated and hydroxy fatty acids | |
Vali et al. | An efficient method for the purification of arachidonic acid from fungal single-cell oil (ARASCO) | |
WO1996037587A1 (en) | Production of materials high in long chain polyunsaturated fatty acids | |
CN110590545A (en) | Method for completely separating oleic acid and linoleic acid | |
Sitompul et al. | Synthesis of Structured Triglycerides Based on Canarium Oil for Food Application. | |
JP3344887B2 (en) | Method for concentrating fats and oils containing highly unsaturated fatty acids | |
JP3340182B2 (en) | Method for producing triglyceride containing docosahexaenoic acid | |
JP2001054396A (en) | Production of oil and fat containing highly unsaturated fatty acid using lipase | |
Ju et al. | High-purity γ-linolenic acid from borage oil fatty acids | |
CN102827886A (en) | Method for preparing textural soya bean lecithin through molecular control technology | |
Wanasundara et al. | Omega-3 fatty acid concentrates: a review of production technologies | |
JPH04126798A (en) | Method for separating free fatty acid from glyceride containing free fatty acid | |
JP3734905B2 (en) | Method for purifying omega-3 polyunsaturated fatty acids | |
JPS62278991A (en) | Production of highly unsaturated fatty acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |